Stockreport

Molecular Partners Finalizes License Agreement With Novartis For Ensovibep For COVID-19 [TheStreet.com]

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF Agreement grants global rights of ensovibep to Novartis, who will lead further development and commercialization of the program Financial terms include milestone paymen [Read more]